Good Day BIO Newsletter Archive | February 8, 2024
BIO Board member Eddie J. Sullivan testified on the Hill yesterday about the impact an expanded IP waiver would have on innovative biotechs like SAb Biotherapeutics—we have a recap, as well as yesterday’s House vote to prohibit the use of QALYs in federal programs. (532 words, 2 minutes, 39 seconds)